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Supplementary Figure S1. Mutations (green spheres) mapped on the crystal structure of 
katG. KatG is a homodimer and the two protomers are shown in grey and pink. Heme is 
shown in brown spheres. (PDB ID: 1SJ2) 
  
 
Supplementary Figure S2. Mutations mapped on the crystal structure of inhA (PDB ID 1ZID). 
The four subunits of the inhA homotetramer are coloured differently. Residues having 
mutations are shown in green spheres and the INH-NAD adduct (ZID, isonicotinic-acetyl-
nicotinamide-adenine dinucleotide) is shown in yellow spheres. 
 
  
 Supplementary Figure S3. A) The inhA wild-type residue I194 (green) is located near the INH-
NAD adduct (yellow) binding site and is involved in making hydrophobic contacts with T196 
and W230. B) The mutant residue T21 with a polar and shorter side-chain causes the loss of 
hydrophobic interactions with W230. C) The wild-type residue I21 (green) is located near 
the INH-NAD adduct (yellow) binding site and is involved in making hydrophobic contacts 
with V238 and M147. D) The mutant residue T21 with a polar side-chain causes the loss of 
hydrophobic interactions with V238 and M147. (.tiff) 
 
  
 Supplementary Figure S4.  Residues in rpoB (chain C in PDB ID 5uhc) coloured according to 
conservation scores calculated by ConSurf. Most rifampicin-resistant mutations occur in the 
highly conserved residues of the rifampicin binding pocket. (.tiff) 
 
  
  
Supplementary Figure S5. A) The wildtype residue H445 in rpoB is involved in making 
carbon-pi and donor-pi interactions with R448 and V168 and hydrophobic interactions with 
D435.  B) The mutant residue R445 loses the carbon-pi and donor-pi interactions, gains a 
weak hydrogen bond with RFP and causes a steric clash with D435. C) The mutant residue 
Y445 gains a hydrogen bond and weak hydrogen bond with RFP and carbon-pi and donor-pi 
interactions with D435. (.tiff) 
  
  
Supplementary Figure S6. A) The wild-type residue L452 in rpoB makes hydrophobic 
interactions with rifampicin.  B) The mutant residue proline loses the hydrophobic 
interactions with the drug. (.tiff) 
 
  
  
Supplementary Figure S7. The rpoB wildtype V359 makes carbon-pi interactions with Y338 
and hydrophobic interactions with Y338, L342 and M349. B) The shorter side-chain of the 
mutant A359 loses carbon-pi contact with Y338 and hydrophobic interactions with L342 and 
M349. (.tiff) 
 
  
  
Supplementary Figure S8. A) The wildtype residue S428 in rpoB forms hydrogen bond with 
Q429 which is in turn making weak hydrogen bonds with the drug. It also forms a weak 
hydrogen bond with F424. B) The mutant residue R428 loses its hydrogen bonds with Q429 
and and F424 and gains a hydrogen bond with Q382. (.tiff) 
 
  
  
Supplementary Figure S9. Residues with mutations (green spheres) in rpoC are mapped on 
the RNA Polymerase assembly (PDB ID 5UHC). The mutations V483G, L516P, and I491T are 
located near the interface with rpoA and rpoZ while the mutation N416T in rpoC is located 
at the interface with rpoB. (.tiff) 
 
  
  
Supplementary Figure S10. A) The wild-type residue L516 in rpoC is involved in making 
hydrophobic contacts with I491, L487, E488 while B) the pyrrolidine ring of the mutated 
residue P516 causes a steric clash with I491. (.tiff) 
  
  
Supplementary Figure S11. A) The wild-type residue N416 in rpoC (yellow ribbon) forms a 
hydrogen bond with the side chain guanidinium NH1 of R412 and a weak hydrogen bond 
with the backbone of R412. B) The mutated residue T416 gains an additional weak hydrogen 
bond with the side chain CD of R412. It also gains a weak hydrogen bond with S1120 and 
hydrophobic contacts with T1053 from the rpoB subunit (grey ribbon). (.tiff) 
  
  
Supplementary Figure S12. A) The wild-type residue V483 in rpoC forms a carbon-pi contact 
with W484 and hydrophobic interactions with L460, V476, L449, and W484 while B) the 
mutated residue glycine loses all the interactions with the surrounding residues. (.tiff) 
 
 
Supplementary Table S1. Sequence Read Archive accessions for the 98 samples used in this 
study. (.xls) 
 
